tiprankstipranks
Advertisement
Advertisement

PRNAF Stock Latest News

Alterity Investors Approve Resolutions, Clearing Path Toward Pivotal MSA Trial
Company AnnouncementsAlterity Investors Approve Resolutions, Clearing Path Toward Pivotal MSA Trial
3d ago
Alterity Therapeutics publishes quantitative susceptibility mapping MRI data
PremiumThe Fly
Alterity Therapeutics publishes quantitative susceptibility mapping MRI data
20d ago
ATHE
Alterity Therapeutics Showcases MSA Program Ahead of Phase 3 Push
PremiumCompany Announcements
Alterity Therapeutics Showcases MSA Program Ahead of Phase 3 Push
25d ago
Alterity advances ATH434 toward Phase 3 in Multiple System Atrophy after FDA backing
PremiumCompany Announcements
Alterity advances ATH434 toward Phase 3 in Multiple System Atrophy after FDA backing
1M ago
Alterity Therapeutics Sets Virtual General Meeting for May 29, 2026
PremiumCompany Announcements
Alterity Therapeutics Sets Virtual General Meeting for May 29, 2026
1M ago
Alterity Therapeutics receives FDA feedback after second ATH434 Type C meeting
PremiumThe FlyAlterity Therapeutics receives FDA feedback after second ATH434 Type C meeting
1M ago
ATHE
Alterity Wins FDA Backing on CMC Plan for ATH434 Phase 3 in Multiple System Atrophy
Premium
Company Announcements
Alterity Wins FDA Backing on CMC Plan for ATH434 Phase 3 in Multiple System Atrophy
1M ago
Alterity Therapeutics presents new data analyses from ATH434 trial
Premium
The Fly
Alterity Therapeutics presents new data analyses from ATH434 trial
1M ago
ATHE
Alterity’s ATH434 Shows Phase 2 Efficacy Signal in MSA on New Composite Scale
PremiumCompany Announcements
Alterity’s ATH434 Shows Phase 2 Efficacy Signal in MSA on New Composite Scale
1M ago
Alterity Therapeutics Names Ann Cunningham to Board With No Initial Shareholding
PremiumCompany Announcements
Alterity Therapeutics Names Ann Cunningham to Board With No Initial Shareholding
1M ago
Alterity Therapeutics Grants 27 Million Unlisted Options Under Incentive Scheme
PremiumCompany Announcements
Alterity Therapeutics Grants 27 Million Unlisted Options Under Incentive Scheme
1M ago
Alterity Therapeutics Issues 212 Million Unlisted Options Under Employee Incentive Plan
PremiumCompany Announcements
Alterity Therapeutics Issues 212 Million Unlisted Options Under Employee Incentive Plan
1M ago
Alterity Therapeutics appoints Cunningham to Board of Directors
PremiumThe FlyAlterity Therapeutics appoints Cunningham to Board of Directors
1M ago
ATHE
Alterity Therapeutics Adds Veteran Biotech Executive Ann Cunningham to Board
Premium
Company Announcements
Alterity Therapeutics Adds Veteran Biotech Executive Ann Cunningham to Board
1M ago
Alterity to Spotlight ATH434 MSA Data in Late-Breaker at AAN Meeting
Premium
Company Announcements
Alterity to Spotlight ATH434 MSA Data in Late-Breaker at AAN Meeting
2M ago
Alterity Therapeutics Showcases ATH434 Progress in Virtual MSA KOL Event
PremiumCompany Announcements
Alterity Therapeutics Showcases ATH434 Progress in Virtual MSA KOL Event
2M ago
Alterity Flags Risks Around Forward‑Looking Corporate Outlook
PremiumCompany Announcements
Alterity Flags Risks Around Forward‑Looking Corporate Outlook
2M ago
Alterity Therapeutics receives regulatory feedback from FDA regarding ATH434
PremiumThe Fly
Alterity Therapeutics receives regulatory feedback from FDA regarding ATH434
2M ago
ATHE
Alterity Wins FDA Backing on Key Elements of ATH434 Phase 3 Plan
PremiumCompany Announcements
Alterity Wins FDA Backing on Key Elements of ATH434 Phase 3 Plan
2M ago
Alterity Therapeutics to Issue 61.5 Million Unlisted Options Under Incentive Plan
PremiumCompany AnnouncementsAlterity Therapeutics to Issue 61.5 Million Unlisted Options Under Incentive Plan
2M ago
Alterity Therapeutics Plans Issue of 150 Million Options on ASX
Premium
Company Announcements
Alterity Therapeutics Plans Issue of 150 Million Options on ASX
2M ago
Alterity Therapeutics Launches Facility to Sell Small Share Parcels
Premium
Company Announcements
Alterity Therapeutics Launches Facility to Sell Small Share Parcels
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >